Unity Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch UNBX and buy or sell other stocks, ETFs, and their options commission-free!About UNBX
Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees16
Employees16
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2009
Founded2009
Employees16
Employees16
UNBX Key Statistics
Market cap965.60K
Market cap965.60K
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume54.60K
Average volume54.60K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.10
52 Week high$3.10
52 Week low$0.0487
52 Week low$0.0487
Stock Snapshot
As of today, Unity Biotechnology(UNBX) shares are valued at $0.06. The company's market cap stands at 965.6K, with a P/E ratio of -0.03.
On 2025-12-06, Unity Biotechnology(UNBX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Unity Biotechnology(UNBX) stock has reached 0, versus its average volume of 54.6K.
The stock's 52-week range extends from a low of $0.05 to a high of $3.10.
The stock's 52-week range extends from a low of $0.05 to a high of $3.10.
People also own
Based on the portfolios of people who own UNBX. This list is generated using Robinhood data, and it’s not a recommendation.